Merck Foundation reiterates Senegal healthcare commitment
Kelej |
Dr. Rasha Kelej, CEO, Merck
Foundation recently met Macky Sall, President of Senegal to discuss MF’s strong
and long-term commitment to build healthcare capacity in Senegal.
MF is the philanthropic arm of
Merck KGaA Germany.
“I am proud and elated to meet
The President to discuss Merck Foundation’s commitment to improve the health
and wellbeing of people of Senegal by improving access to quality and equitable
healthcare in the country,” said Kelej.
During the meeting, she also
finalized MF’s annual conference, 5th edition of Merck Africa Asia Luminary to
be conducted at CICAD, Dakar, Senegal on 30, 31 October 2018 under the
patronage of Sall and The First Lady of Senegal, Marieme Faye Sall, and in
partnership with the Ministry of Health of Senegal.
It will be attended by more than
450 healthcare providers, policy makers, academia and researchers from over 45
African and Asian countries. The objective is to improve disease management,
early detection and prevention, build healthcare and scientific research
capacity and improve access to quality and equitable healthcare solutions
across Africa and Asia.
Kelej also conducted a meeting
with the Minister of Health of Senegal, Abdoulaye Diouf Sarr, to discuss the
procedure for providing one and two-year oncology fellowship to Senegalese
doctors for the next five years. They also talked about training for fertility
specialists to improve access to quality fertility care in the country and
providing Diabetes Diploma in French to improve diabetes care in Senegal.
“We are excited to partner with
Merck Foundation and are happy with their strong commitment and the efficient
execution of their programs in the country,” said Sarr.
Moreover, Kelej was invited by
World Health Organization, WHO, during its Regional Meeting for African
Ministers of Health in Dakar, to share her experience in conducting Merck More
Than a Mother campaign to improve access to fertility care and break the stigma
around infertile women.
“It was my pleasure to be a part
of WHO’s Regional Meeting for Ministers of Health of Africa to discuss the
inclusion of fertility care on the global health agenda. I look forward to a
long-term relation with WHO to improve access to quality and equitable
fertility care solutions and include infertility in the global health agenda.
It is now time for my dream, to empower infertile women and couples in Africa
and developing countries, to come true,” Kelej concluded.
About Merck Foundation
The Merck Foundation
(www.Merck-Foundation.com), established in 2017, is the philanthropic arm of
Merck KGaA Germany, aims to improve the health and wellbeing of people and
advance their lives through science and technology. Our efforts are primarily
focused on improving access to innovative healthcare solutions in underserved
communities, building healthcare and scientific research capacity and
empowering people in STEM (Science, Technology, Engineering, and Mathematics)
with a special focus on women and youth. All Merck Foundation press releases
are distributed by e-mail at the same time they become available on the Merck
Foundation website.
Please go to
www.Merck-Foundation.com to read more and/or register online to interact and
exchange experience with our registered members.
About Merck
Merck is a leading science and
technology company in healthcare, life science and performance materials.
Almost 53,000 employees work to further develop technologies that improve and
enhance life – from biopharmaceutical therapies to treat cancer or multiple
sclerosis, cutting-edge systems for scientific research and production, to
liquid crystals for smartphones and LCD televisions. In 2017, Merck generated
sales of € 15.3 billion in 66 countries.
Founded in 1668, Merck is the
world's oldest pharmaceutical and chemical company. The founding family remains
the majority owner of the publicly listed corporate group. Merck holds the
global rights to the Merck name and brand. The only exceptions are the United
States and Canada, where the company operates as EMD Serono, MilliporeSigma
About Merck Oncology Fellowship Program
The Merck Oncology Fellowship
Program, a key initiative of Merck Cancer Access Program, focuses on building
additional capacity through medical education and training.
The lack of financial means is
not the only challenge in Africa and developing countries, but a scarcity of
trained health care personnel capable to tackle the prevention, early diagnosis
and management of cancer at all levels of the health care systems is even a
bigger challenge.
Merck Oncology Fellowship Program
focuses on building professional cancer care capacity with the aim to increase
the limited number of oncologists in Africa and Developing countries. The
program provides One-year fellowship program at Tata Memorial Centre - India,
One and half-years Oncology Fellowship programs at University of Malaya -
Malaysia, Two years Oncology Fellowship Program at University of Nairobi -
Kenya and Two years Master degree in Medical Oncology at Cairo University -
Egypt, in partnership with African Ministries of Health, Local Governments and
Academia.
Launched in 2016, over 43
candidates from more than 17 African countries have rolled in the Merck
Oncology Fellowship Program. The program will continue to build cancer care
capability in African countries such as Botswana, Cameroon, CAR, Ethiopia,
Gambia, Ghana, Guinea, Liberia, Mauritius, Namibia, Niger, Nigeria, Rwanda,
Senegal, Tanzania, Uganda and Zambia.
About Merck More Than a Mother campaign
In many cultures, childless women
suffer discrimination, stigma, and ostracism. Their inability to have children
results in great isolation, disinheritance, and assaults. “Merck More Than a
Mother” empowers such women through the access to information, health, change
of mindsets and economic empowerment.
As part of this Campaign, we
started “Empowering Berna” project in Africa to help childless and infertile
women starting their own business and thus achieve financial independence and
become stronger and happier. The project has benefited more than 1,000 women
across the continent.
Also, part of the campaign is our
Merck Embryology & Fertility Training Program, a three-month hands-on
practical course to establish the platform of fertility specialists across
Africa and Asia.
Merck Foundation provided for
more than 50 candidates, three months to six months clinical and practical
training for fertility specialists and embryologists in more than 29 countries
across Africa and Asia such as: Chad, Niger, Central African Republic, Cote
D’Ivoire, Ghana, Ethiopia, Uganda, Kenya, Tanzania, Zambia, Nigeria, Benin,
Mali, Burkina Fuso, Senegal, Guinea Conakry, Sierra Leone, Liberia, Cameron,
Rwanda, Botswana, DR Congo, Congo
Brazzaville, Gambia, Nepal, Sri Lanka, Bangladesh, Myanmar and Cambodia.
Merck Foundation is making
history in many African countries where they never had fertility specialists or
specialized fertility clinics before Merck More Than a Mother intervention, to
train the first fertility specialists such as in Sierra Leone, Liberia, The
Gambia, Niger, Chad, and Guinea.
Merck Foundation plan supported
the establishment of the first public IVF centers in Ethiopia and Uganda
through providing the clinical and practical training necessary for their staff.
Merck Foundation also plans to support the establishment of the first public
IVF in Tanzania soon.
Merck More Than a Mother,
launched in 2015, is a program of the Merck Foundation, the foundation drives
many of our initiatives and programs in the area of build health care and
research capacity and improves access to equitable healthcare solutions.
Join the conversation on our social
media platforms below and let your voice be heard.
Facebook: https://bit.ly/2MmUl3p
Twitter: https://bit.ly/2NDqHLR
Youtube: https://bit.ly/2K3ACZp
Website:
https://www.Merck-Foundation.com
Join Merck Foundation online
community to exchange experience and information with other healthcare
providers, researchers, students, policy makers and community members in Africa
and beyond www.Merck-Foundation.com free registration
Comments
Post a Comment